Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity
Authors
Keywords
-
Journal
eLife
Volume 5, Issue -, Pages -
Publisher
eLife Sciences Organisation, Ltd.
Online
2016-05-31
DOI
10.7554/elife.11156
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structure of the p300 Histone Acetyltransferase Bound to Acetyl-Coenzyme A and Its Analogues
- (2014) Jasna Maksimoska et al. BIOCHEMISTRY
- Chemoproteomic Profiling of Lysine Acetyltransferases Highlights an Expanded Landscape of Catalytic Acetylation
- (2014) David C. Montgomery et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The Effects of Salsalate on Glycemic Control in Patients With Type 2 Diabetes
- (2013) Allison B. Goldfine ANNALS OF INTERNAL MEDICINE
- A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance
- (2013) A. B. Goldfine et al. DIABETOLOGIA
- NPR3 and NPR4 are receptors for the immune signal salicylic acid in plants
- (2012) Zheng Qing Fu et al. NATURE
- The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase
- (2012) S. A. Hawley et al. SCIENCE
- AMP-Activated Protein Kinase Suppresses Endothelial Cell Inflammation Through Phosphorylation of Transcriptional Coactivator p300
- (2011) Yuan Zhang et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Life and death of transcriptional co-activator p300
- (2011) Jihong Chen et al. Epigenetics
- Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment
- (2011) Jürgen Cox et al. JOURNAL OF PROTEOME RESEARCH
- The Leukemogenicity of AML1-ETO Is Dependent on Site-Specific Lysine Acetylation
- (2011) L. Wang et al. SCIENCE
- An electrophoretic mobility shift assay for the identification and kinetic analysis of acetyl transferase inhibitors
- (2010) Caroline Fanslau et al. ANALYTICAL BIOCHEMISTRY
- Histone acetyl transferases as emerging drug targets
- (2009) Frank J. Dekker et al. DRUG DISCOVERY TODAY
- CBP/p300-mediated acetylation of histone H3 on lysine 56
- (2009) Chandrima Das et al. NATURE
- Two cell lines of t(8;21) acute myeloid leukemia with activating KIT exon 17 mutation: models for the ‘second hit’ hypothesis
- (2008) H Becker et al. LEUKEMIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started